Eric Walters currently serves as Treasurer and a Board Member of MDG Boston since July 2018.  During his tenure at MDG, he has managed the financial resources of MDG.  He provides keen insight into strategic planning, business development, product advancement, organizational infrastructure and governance initiatives.

He is a Certified Public Accountant (CPA) with broad experience leading all aspects of the financial landscape including planning, analysis, budgeting, Big Four audit, capital efficiency, internal controls, and cash and treasury management.

He has a comprehensive background in mergers & acquisitions, divestitures, private fund raisings, venture capital, IPOs and SEC filings. He helped drive the growth of a $1M start-up (PolyMedica) to a successful $350M publicly held company, which was later sold in 2007 for approximately $1.5B in cash when revenues were $675M. Sale price per share was 8x IPO share price.

He has been a senior financial executive in both private and publicly-held medical device and health care companies for more than 20 years. He has raised more than $100M in capital and managed Wall Street investor relations for a publicly-held corporation with a $1B market capitalization.

He is a co-founder of the New England Healthcare Executives Network (NEHEN).

Currently, Mr. Walters is CEO, Director and a Co-Founder of ONEighty C Technologies Corporation.  The Company owns WAVEPulse Sterilization TM, a proprietary and first-to-market high-performance sterilization process targeting deficiencies with existing high level disinfection systems in hospitals and other medical institutions which do not adequately sterilize reusable medical devices.

Dr. Qiu is an accomplished biopharma executive consultant with 25 year US and international experience in leading some of the most exciting ophthalmic therapeutic innovations: stem cell & gene therapy, drug discovery & delivery, and combination product development. Recently she served as Consulting Chief Scientific & Medical Officer for Lineage Cell Therapeutics, helping remove the key stumbling blocks and creating product values for the OpRegen hRPE line, which contributed to the $670M deal with Roche/Genentech. She pioneered the use of 41G minimally invasive subretinal gene delivery, which became the standard of care today. She helped Inotek Pharma to rebuild multi-million $ R&D pipelines at zero cost and contributed to the IPO success. During the COVID19 spring surge in 2020, she spearheaded the UK-US strategic task force consortium for global therapeutic development, saving countless lives. As an expert of ocular drug delivery, she helped clients design top tier product lines capturing a $20B market cap with unmatched speed and quality. She started her career at GSK, where she built the first Ophthalmology business unit. As a trusted medical advisor, she excelled at Astellas Pharma, Sanofi, Regeneron, LambdaVision and Ocular Therapeutics.

She has a Medical Doctor degree (with honors) from Nanchang University, a Doctorate of Ophthalmology from National Sun Yat-sen University in collaboration with Sheie Eye Institute/UPENN on a PhD thesis project in stem cell transplant, followed by post-doctoral trainings at Boston University and University of Southern California. She was a board certified Ophthalmologist in China; an elected member of American Academy of Ophthalmology.

Driven by mission to improve and save lives through innovations in health care, I am the Sr. Director of digital health strategy and innovations for Cognizant, a global consulting and services firm.

In this capacity, I am delivering strategic services for health sciences clients, including F100 medical device and pharma clients. Prior to this role, I co-founded Cognizant Accelerator, an internal business incubator, where I developed sustaining business strategies for new ventures.  Outside of Cognizant, I am actively involved in advising several digital health startups, new venture groups and health organizations. These include being a mentor/judge for MassChallenge, owner of LinkedIn Medtech group (11k members), membership in MassBio, and Georgia Tech Health ventures. I am a graduate of MIT, and have a bachelor’s degree in Electrical and Computer Engineering and a Master of Science degree in management.

If fortunate enough to serve on Board of Directors for MDG Boston, I would leverage my network and broad access, to advocate for increased membership and draw awareness to MDG’s mission and goals. Our industry is at cross-roads in combining traditional medical solutions, digital solutions and new business models to deliver tremendous value to patients – at an unprecedented scale. To stay relevant, it is important that MDG be at the forefront of this transformation.  As a believer in value of innovations in our field, with my experience will draw interest for further collaboration, and thus higher visibility to our work.

It would be an honor to be selected to join this group of distinguished individuals to make a difference to our community and to the patients that benefit from it.

As a progressive, results-oriented Human Resources Executive, I have over 25 years of experience providing thought leadership to CEO’s and senior leadership teams of global organizations within the healthcare, manufacturing, and high-technology/software industries. I am well-versed in all facets of Human Resources including Organizational Effectiveness, Employee Engagement, Change Management, Talent Acquisition, Talent Development, Compensation, Employee Relations, and Labor Relations.

Prior to transitioning to consultancy, my experience includes six years as Vice President Human Resources for Hexagon Manufacturing Intelligence where I reported directly to the CEO and was a key member of Hexagon’s Global Human Resources Leadership Team. Before joining Hexagon, I was with Johnson & Johnson for nearly 20 years in a variety of Sr. Level HR roles across multiple operating companies as well as J&J’s corporate headquarters.

I earned a BS degree in Human Resources Management from the University of Massachusetts and did extensive graduate work in Labor and Industrial Relations at the University of Rhode Island along with the completion of an advanced executive education program at Cornell University.

As a member of the MDG Board this past year, I’ve leveraged my organizational effectiveness skills, assisting the team in putting additional structure in place that will contribute to the achievement of MDG’s vision. I look forward to the prospect of continuing to serve on the board and playing a key role in driving the organization’s growth and continued success.

Ilsa Webeck is a creative healthcare professional with over 20 years of strategy, marketing and product development experience. As the founder of MedTech Strategies, she sits at the nexus of product development and commercialization, working with companies of all sizes to identify product value propositions and actionable outcomes for growth.

Her past roles include corporate planning, product management and early product strategy at HeartWare, Biogen, Johnson & Johnson’s DePuy Spine and Health Advances.

Ilsa holds a BA in Biology from Dartmouth College and an MBA from the Tuck School of Business.  As Course Director for Harvard Catalyst, she directed the TRANSCEND program for startups and entrepreneurs looking to improve their approach to growing their business.  Additionally, she is a judge and mentor for MassChallenge.

For the last 4 years, Ilsa spearheaded several MDG Boston programs which helped the organization weather the pandemic and be positioned for future success.  She lead the development of the new branding, website (with pages such as: expert advice, jobs postings, community connections) and communication approaches, drove the new sponsorship engagement program and spearheaded the strategic planning retreat resulting in organizational alignment for the future.

Ilsa looks forward to two more years on the board, where she can continue to expand on the work done to date (i.e., launch the new member and sponsor portals) and continue to establish MDG Boston as a premier networking and educational organization in the medtech industry.

MDG’s membership value proposition should include the following:
–  Education & Development – Professional advancement through learning evolving global medical technology trends

–  Networking Opportunities – Provide a setting for membership to expand their professional networks, and to strengthen their collaborations

–  Entrepreneurship – Exposure to innovative ideas, including identification of new market opportunities

These ideas should be embedded the organization’s public facing communications, statements, social media presence, and public relations initiatives.

Who is MDG?  A core belief of MDG membership is that advances in technology often lead to substantial improvements in health care outcomes, efficiency, and costs.  Although based in the Boston area, MDG membership may extend geographically throughout New England, with significant potential to expand globally.  As a hub for healthcare technology Greater Boston affords an excellent location with prominent academic institutions, world-class medical centers, manufacturers, and a wealth of human resource talent.  MDG’s brand, as well as its communication strategies should reflect these core beliefs.

MDG’s Focus:  The focus of MDG should be on the individual – professionals who are engaged in the medical technology industry or are looking to enter.  They are engineers, regulatory and reimbursement specialists, commercialization professionals, quality specialists, attorneys, clinicians, finance professionals, and more.  MDG’s communication focus should reinforce that membership provides life-long opportunities for learning, professional networking, and entrepreneurship in the global medical technology industry.  Over time, this may also include biotechnology, and biopharmaceutical related content in addition to medical device related discussions.

I believe in MDG Boston’s strategic focus of building community and communicating its identity through unique programming.  In line with MDG Boston’s mission, I believe the next few years should be geared toward enhancing membership experiences, delivering competitive forums with relevant content with diverse representation, and expanding sponsor relationships.

Much of my professional experience in the MedTech industry has been centered on understanding key markets, target customers, and an organization’s value proposition. Through these experiences, I have achieved business successes by building long term strategic direction.  Importantly, I work with the leadership team to build an execution plan with achievable metrics that allows an organization to live into the strategy.

This can be done by building individual relationships that foster mentoring, learning, development, and industry transformation, with MDG shaping a long term, “way of life” in the MedTech industry.  I am confident that I can work with the MDG Boston team to make a lasting impression in this organization as I did at Johnson and Johnson as a part of successful, innovative and hardworking teams.  I would bring that same work ethic to the board.

I often work to build alignment amongst cross functional teams of leaders such that strategy and tactics speak to the culture of the community. I also have long term experiences shaping complex value stories for audiences. I look forward to bringing this approach and skill set to the new board.

She is the Director of Quality at a medium sized medical device company in central Massachusetts. She has been in the Director role for 12 years and was previously a Quality Engineer at the same company for 7 years. She is a long-term member of ASME, SWE, and ASQ.

Loretta has volunteered with the American Society of Mechanical Engineers (ASME) since 1995 at the college, local, and national level. As part of several of her volunteer roles, Loretta has been the Chair of two groups focused on membership growth and retention within ASME: early career engineers and women in engineering. She looks forward to utilizing her experiences from ASME with finding value for membership with MDG Boston in today’s challenging environment. In Loretta’s free time, she likes to train for and run half marathons – #28 is on the calendar for October 2022.

I am a Partner in Goodwin Procter’s Boston office and co-leader of its MedTech practice.  I am a corporate lawyer and registered patent attorney and specialize in representing medical device companies of all sizes (including start-ups), and their investors, in corporate and IP matters throughout the business life cycle.  I also lead a sector group focused on the incorporation of artificial intelligence and machine learning technologies into medical products.  Before becoming a lawyer I was a mechanical engineer that designed x-ray systems.

During my career, I’ve worked with businesses across many sectors, but decided several years ago to focus heavily on medical device companies.  I am deeply passionate about technology that can make a difference in patients’ lives – and being a MechE, found devices much more interesting that drugs!  I’m consistently blown away by my client’s ingenuity and brilliance in creating products that have such great impact in the world.  And as a lawyer to many such companies, I get to live the story over and over again, which is a great joy.

I am seeking a position on the MDG Boston board because I genuinely believe my background and connections in the industry can add significant value to the group, and I am very interested in becoming deeper engrained in the Boston MedTech ecosystem.  I am also interested in attending/hosting more in person networking and educational events.

As the Director of Marketing for a Boston-based IP law firm, Hamilton Brook Smith Reynolds, I have thoroughly enjoyed sponsoring MDG Boston, assisting in Forum programming, and providing feedback on the value of sponsoring. My perspectives over the last 6 years on the MDG Boston marketing strategy, combined with the opportunity to develop inter-sponsor relationships, provide an untapped opportunity to educate and lead our community in serving MDG Boston’s mission.

I believe that Sponsor Advocate’s legwork begins with contacting each sponsor directly, gaining feedback, and encouraging them to schedule events and build relationships. Sponsors are looking to give back to the community first and, of course, generate new business.

Key activities for the Sponsor Advocate are to:

a)     help sponsor companies to develop topics that share their knowledge,

b)    solicit sponsor partnerships to create integrated programming, and

c)     reach out to the membership base to gain new speakers.

A key event for the coming year is to get the sponsorship companies together for a social event. Additionally, I am interested in getting Massachusetts-based universities involved with MDG Boston. I am impressed with the thought leadership and community outreach MDG Boston has achieved.

I believe developing long-term personal relationships within the community is vital to MDG Boston’s mission.